Infection with hepatitis C genotype 1 or mixed hepatitis C genotype;

Asymptomatic or nearly asymptomatic from hepatitis C;

Previous therapy with interferon and ribavirin or peginterferon and ribavirin without an SVR or relapsed following an SVR;or Interferon naive subjects

Chronically infected (at least 6 months since diagnosis) HCV-positive subjects;

No evidence of bridging necrosis or cirrhosis;

Liver biopsy within the last 2 years

A Study of MDX-1106 to Treat Patients With Hepatitis C Infection

What this study is about